FDA
-
FDA Issues Import Alerts and Warnings to Block Illegal Semaglutide and Tirzepatide Shipments from Asia
The FDA is targeting unapproved obesity drugs from India, Japan, and China through import alerts, public warnings, and…
Most read
-
Laos’ 600MW Monsoon Wind Project Pivots ‘Battery of Asia’ to Cross-Border Green Power
-
Melbourne Premier Vows Gig Worker Safety After Chinese Rider Stabbing
-
Japan Supplies Half of ITER’s Superconducting Magnets and Leads Tritium Breeding Tests
-
Southeast Asia Rewrites the Rules of the Datacentre Arms Race
-
Jianming Feng killing sparks community safety concerns in Melbourne
-
Japan’s $27M Radar and Drones Boost Philippines’ Maritime Security and Tourism
-
Why South-East Asia Is The Perfect Winter-Sun Escape For British Travellers In 2026
-
Japan’s Restaurant of Mistaken Orders Reframing Dementia Through Hospitality
-
Spiritual travel fuels mindful tourism and economic growth in India’s remote regions
-
Oakland’s October Dining Wave Adds Asian Comfort Food Options
-
Japan’s National Cancer Center Says Dendritic Cell Vaccine Effectiveness Is Unproven
-
What China’s Approval of the First Solid-Tumor CAR-T Therapy Means for Patients Across Asia
-
North Korean Missile Test Leaves Asia Flights Running, but Tourism Risks Loom
-
Saudi Arabia Pulls Anti-Israel Textbook and Content From Curriculum, Study Finds
-
Japan’s Population to Drop to 87 Million by 2060: Official Projections